| Copyright © 2009. National Academy of Sciences. All rights reserved. Terms of Use and Privacy Statement |
Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 111
An International Perspective on Advancing Technologies and Strategies for Managing Dual-Use Risks: Report of a Workshop
Appendixes
OCR for page 112
An International Perspective on Advancing Technologies and Strategies for Managing Dual-Use Risks: Report of a Workshop
This page intentionally left blank.
OCR for page 113
An International Perspective on Advancing Technologies and Strategies for Managing Dual-Use Risks: Report of a Workshop
Appendix A
Workshop Agenda
Advancing Technologies: Surveying the Global Capacity for Research, Development, and Application
Policy and Global Affairs Division/National Research Council
The Board on Global Health/ Institute of Medicine
The National Academies
September 21-September 22, 2004
Instituto Nacional de Salud Publica
Cuernavaca, Mexico
Committee on Advances in Technology and the Prevention of Their Application to Next Generation
Bioterrorism and Biological Warfare Threats
AGENDA
Tuesday, September 21, 2004
8:30
Coffee
9:00
Welcome and Opening Remarks/Goals of the Meeting
Stanley Lemon, M.D., Committee Co-Chair/The University of Texas Branch at Galveston
David Relman, M.D., Committee Co-chair/ Stanford University
Mauricio Hernandez, M.D., Instituto Nacional de Salud Publica, Cuernavaca, Mexico
OCR for page 114
An International Perspective on Advancing Technologies and Strategies for Managing Dual-Use Risks: Report of a Workshop
Session I: Drivers of Global Technological Development
Moderator: David Relman, M.D., Committee Co-chair/ Stanford University
9:45
The Economic Opportunities of the Global Workforce and Marketplace (comparative advantage; market capture; select workforce)
Terence Taylor, IISS-US
10:05
Q&A/Discussion
10:20
Technological Approaches to Overcoming Health and Development Challenges
David Banta, M.D., WHO and World Bank Consultant
10:40
Discussion
11:00-11:15
BREAK
Session II: The Global Landscape of Technology/Efforts to Mitigate Risks for Misapplication
Moderator: Stanley Lemon, M.D., Committee Co-Chair/ The University of Texas Branch at Galveston
11:15-11:35
Global Cooperation in the Development of Biotechnology
Decio Ripandelli, International Centre for Genetic Engineering and Biotechnology
11:35-12:00
Discussion
12:00
LUNCH
1:00-2:15
AGRICULTURE/ LIVESTOCK BREEDING/BIOPhARMING
1:00-1:45
Panel Discussion:
Charles Arntzen, Ph.D., Arizona State University, and
Miguel Gomez Lim, Ph.D., CINVESTAV-Irapuato, Mexico
Luis Herrera-Estrella, Ph.D., Center for Research and Advanced Studies, National Polytechnic Institute, Irapuato, Mexico
1:45-2:15
Q&A/Discussion
OCR for page 115
An International Perspective on Advancing Technologies and Strategies for Managing Dual-Use Risks: Report of a Workshop
2:15-3:50
VACCINES, PHARMACEUTICAL DEVELOPMENT AND HUMAN GENOMICS
Panel Discussion:
Rosiceli Barreto Gonçalves Baetas, D.Sc., Biomanguinhos, Fiocruz, Brazil
Jacques Ravel, Ph.D., The Institute for Genomic Research
Patrick Tan Boon Ooi, Ph.D., Genome Institute of Singapore
Abdallah Daar, M.D., Center for Bioethics, University of Toronto
Gerardo Jimenez-Sanchez, National Institute of Genomic Medicine, Mexico
3:50-4:05
BREAK
4:05-5:05
Q&A/Discussion
Session III: Discussion
Moderators:
Nancy Connell, Ph.D., UMDNJ/NJ Medical School
Christopher Chyba, Ph.D., Stanford University and SETI Institute
5:05-6:00
—Open Discussion—-
6:00
Adjournment of Day 1
Wednesday, September 22, 2004
8:30
Coffee
9:00
Opening Remarks / Summary of Day 1
Stanley Lemon, M.D.
Session IV: Safeguarding the Benefits of Technology—Addressing the “Dual-Use” Dilemma
Moderator:
Christopher Chyba, Ph.D., Stanford University and SETI Institute
9:00-9:30
An Update on the BWC Intercessional Meetings, Ambassador Tibor Toth
9:30-10:00
Q&A/Discussion
OCR for page 116
An International Perspective on Advancing Technologies and Strategies for Managing Dual-Use Risks: Report of a Workshop
10:00-11:45
Non-proliferation and Other Mitigation Strategies
Discussion Panel:
10:00-10:15
Amy Sands, Ph.D., Monterey Institute of International Studies
10:15-10:30
Robert Mathews, D.Sc., Australian Defence Science and Technology Organisation
10:30-10:45
Jerome Amir Singh, Ph.D., Nelson R. Mandela School of Medicine, Durban, South Africa
10:45-11:00
Peter Herby, International Committee of the Red Cross, Geneva, Switzerland
11:00-11:15
Terence Taylor, IISS-US
11:15
BREAK
11:30-12:30
OPEN DISCUSSION
12:30-1:30
LUNCH
Session V: Emerging and Converging Technologies
Moderator:
David Relman, M.D., Committee Co-chair/ Stanford University
1:30-3:00
NANOTECHNOLOGY/BIOTECHNOLOGY/CONVERGING TECHNOLOGIES
9:30-10:45
Lead Discussants: Nadrian Seeman, Ph.D., New York University Michael Morgan, Ph.D., The Wellcome Trust
3:00-3:30
Q&A/Discussion
3:30
BREAK
3:45-4:20
POTENTIAL “DUAL-USE” APPLICATIONS of DISCOVERIES IN BIOREGULATORS AND NEUROBIOLOGY:
Kathryn Nixdorff, Ph.D. University of Darmstadt, Germany
Elliott Kagan, M.D., Uniformed Services University of the Health Sciences
4:20-4:30
Q&A/Discussion
4:30-5:00
OPEN DISCUSSION
OCR for page 117
An International Perspective on Advancing Technologies and Strategies for Managing Dual-Use Risks: Report of a Workshop
Session VI: Open Discussion/Q&A
5:00
Moderator: Stanley Lemon, M.D., Committee Co-Chair/The University of Texas Branch at Galveston
—Open Discussion/ Q&A—
6:00
CLOSING REMARKS/ADJOURN
OCR for page 118
An International Perspective on Advancing Technologies and Strategies for Managing Dual-Use Risks: Report of a Workshop
This page intentionally left blank.
Representative terms from entire chapter:
biological weapons